2009 period included $3.0 million related to the sale of certain excipients used in REMOXY(R) to King Pharmaceuticals...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
KING PHARMACEUTICALS (KG)
King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.
King Pharmaceuticals (KG) is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
181 news
and
113 blog
items.
Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from
like-minded professionals.
News
add content
Recent news on this topic.
BRISTOL, Tenn.--(Business Wire)-- King Pharmaceuticals, Inc. (NYSE:KG) announced today that it has licensed from Merck...
Oct 21 (Reuters) - King Pharmaceuticals Inc (KG.N) said U.S. health regulators declined to approve its heart imaging...
(BUSINESS WIRE) -- King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration...
King Pharmaceuticals gets FDA request on stress imaging agent, potentially delaying approval
stop using materials * Shares fall 2 percent WASHINGTON, Oct 20 (Reuters) - Two video news releases for King...
call buyers may profit by expiration if shares of the EWZ rise at least 3% to $78.30. King Pharmaceuticals ( KG - news...
continue to monitor this issue closely,' Wyeth spokeswoman Gwen Fisher said. The FDA also said it was probing King...
Grill & Bar, Covidien, CVS/pharmacy, Dunkin' Donuts, Harvard Pilgrim Health Care, John Hancock, The J.M.
continue to monitor this issue closely,' Wyeth spokeswoman Gwen Fisher said. The FDA also said it was probing King...
millions of viewers. Other 2009 Time To Talk sponsors include Consumer Healthcare Products Association, Comcast, The...
still has the financial wherewithal to work through a downturn. In the meantime, investors are left waiting for King...
not to do it at the expense of our health.' The survey, released Sept. 21, was funded by King Pharmaceuticals, Inc.
BRISTOL, Tenn.--(Business Wire)-- King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast...
development by Alpharma. Terms of the agreement were not disclosed. Alpharma Animal Health, a wholly owned subsidiary...
and caregivers through the support of 2009 sponsors A&E Network, Consumer Healthcare Products Association, Comcast,...
5) EPS Surprise Estimated EPS % Growth Next Qtr Estimated Long-Term Growth ATP Oil & Gas (Nasdaq: ATPG) King...
expect the meeting before end of this year Sept 3 (Reuters) - Acura Pharmaceuticals Inc (ACUR.O) and King...
NEW YORK - King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. said Friday they don't expect to have to run new...
DOW JONES NEWSWIRES Acura Pharmaceuticals Inc.(ACUR) and King Pharmaceuticals Inc. (KG) agreed to take their Acurox...
PALATINE, Ill. & BRISTOL, Tenn.--(Business Wire)-- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King...
thrombin (Recothrom) for surgical bleeding. The company asked the FDA to pull a competing product from Bristol,...
stop bleeding. Yesterday, ZymoGenetics (Nasdaq: ZGEN) went on the offensive, asking the Food and Drug Administration to...
visit www.zymogenetics.com. RECOTHROM® is a registered trademark of ZymoGenetics, Inc. Thrombin-JMI® is a registered...
require a patient hand to book profits. Other mid-cap drug companies hanging tough in this August market include: King...
Top Sources: King Pharmaceuticals (KG)
- MarketWatch
- Reuters
- TheStreet.com
- CNBC
- BusinessWeek
- Seattle Post Intelligencer
- biz.yahoo.com
- Boston Globe
- CNN Money
- drugdiscovery.pharmaceutical-business-review.com
Most Active Users in this Topic
No user contributions
